Revance Therapeutics Ownership | Who Owns Revance Therapeutics?
Revance Therapeutics Ownership Summary
Revance Therapeutics is owned by 38.10% institutional investors, 8.56% insiders, and 53.34% retail investors. Blackrock is the largest institutional shareholder, holding 9.32% of RVNC shares. American Funds SMALLCAP World A is the top mutual fund, with 7.09% of its assets in Revance Therapeutics shares.
RVNC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Revance Therapeutics | 38.10% | 8.56% | 53.34% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 8.57M | 9.32% | $22.01M |
| State street | 2.28M | 2.48% | $5.87M |
| D. e. shaw | 1.37M | 1.31% | $4.16M |
| Morgan stanley | 977.10K | 1.06% | $2.51M |
| Nuveen asset management | 423.19K | 0.41% | $1.29M |
| Barclays | 402.69K | 0.39% | $1.23M |
| Susquehanna group, llp | 303.07K | 0.29% | $921.34K |
| Ubs asset management americas | 237.41K | 0.23% | $721.72K |
| Bank of america corp /de/ | 179.95K | 0.20% | $462.48K |
| Norges bank | 161.00K | 0.15% | $489.44K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Inspire investing | 131.89K | 0.04% | $400.95K |
| Pale fire capital se | 20.00K | 0.01% | $51.40K |
| D. e. shaw | 1.37M | 0.00% | $4.16M |
| Private capital management | 10.00K | 0.00% | $25.70K |
| Caption management | 38.29K | 0.00% | $116.40K |
| Boothbay fund management | 13.48K | 0.00% | $40.97K |
| Jacobs levy equity management | 81.58K | 0.00% | $209.66K |
| Group one trading | 92.38K | 0.00% | $280.83M |
| Naples money management | 300.00 | 0.00% | $771.00 |
| Blackrock | 8.57M | 0.00% | $22.01M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 8.57M | 0.00% | 1.25M |
| Susquehanna group, llp | 303.07K | 0.00% | 246.44K |
| Barclays | 402.69K | 0.00% | 229.34K |
| Norges bank | 161.00K | 0.00% | 161.00K |
| Group one trading | 92.38K | 0.00% | 92.38K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | - | - | -13.94M |
| Blackrock funding, inc. /de | - | - | -8.60M |
| Beryl capital management | - | - | -5.94M |
| Vanguard group | - | - | -5.63M |
| Fil | - | - | -4.20M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 161.00K | 0.00% | 161.00K | $489.44K |
| Group one trading | 92.38K | 0.00% | 92.38K | $280.83M |
| Jacobs levy equity management | 81.58K | 0.00% | 81.58K | $209.66K |
| Caption management | 38.29K | 0.00% | 38.29K | $116.40K |
| Boothbay fund management | 13.48K | 0.00% | 13.48K | $40.97K |
Sold Out
| Holder | Change |
|---|---|
| Toronto dominion bank | -5.00 |
| Eversource wealth advisors | -7.00 |
| Federated hermes | -9.00 |
| Nelson, van denburg & campbell wealth management group | -17.00 |
| Northwestern mutual wealth management | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 79 | -64.57% | 39,701,953 | -51.96% | 38 | 0.61% | 40 | -65.22% | 21 | -61.82% |
| Sep 30, 2024 | 222 | 19.35% | 81,913,828 | 0.64% | 78 | 1.00% | 114 | 28.09% | 55 | 30.95% |
| Jun 30, 2024 | 185 | -8.87% | 81,390,810 | -2.08% | 88 | 0.92% | 88 | -15.38% | 42 | -12.50% |
| Mar 31, 2024 | 203 | -6.02% | 83,118,620 | 15.30% | 98 | 1.42% | 104 | -9.57% | 48 | -2.04% |
| Dec 31, 2023 | 216 | 2.37% | 72,091,641 | -7.09% | 83 | 0.97% | 115 | 11.65% | 49 | -9.26% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 7.38M | 7.09% | - |
| American Funds New Economy A | 6.33M | 6.08% | -3.96K |
| Capital Group New Economy Comp | 6.33M | 6.08% | -3.96K |
| Vanguard Total Stock Mkt Idx Inv | 2.97M | 2.84% | - |
| iShares Russell 2000 ETF | 2.87M | 2.75% | - |
| Fidelity Canadian Large Cap Sr B | 2.45M | 2.34% | - |
| Franklin Biotechnology Discv A(acc)USD | 1.95M | 1.87% | - |
| Arbitrage R | 1.59M | 1.53% | 164.00K |
| Federated Hermes MDT Small Cap Core IS | 1.51M | 1.45% | 516.10K |
| Federated Hermes MDT SCC Institutional | 1.51M | 1.45% | 516.10K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 18, 2024 | Hollander David | CMO & Global Therapeutics Lead | Sell | $16.30K |
| Apr 16, 2024 | Jordan Erica | Chief Commercial Officer | Sell | $9.10K |
| Mar 18, 2024 | Sjuts Dustin S | President | Sell | $46.45K |
| Mar 18, 2024 | Moxie Dwight | CLO & GC | Sell | $40.97K |
| Mar 18, 2024 | Schilke Tobin | CFO | Sell | $47.20K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q2 | - | 1 |
| 2024 Q1 | 1 | 3 |
| 2023 Q4 | - | - |
| 2023 Q3 | - | 5 |
RVNC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools